Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Hen (Chicken) Market Analysis Report 2026: $379.8 Bn Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

May 1, 2026

Zapdos Labs Raises $500K to Bring AI Video Agents to Factory Floors

May 1, 2026

Pharmaceutical Manufacturing Software Market Analysis Report 2026: $7.87 Bn Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

May 1, 2026

Pluristyx and Qkine Announce a Reciprocal Distribution Agreement in Support of Optimized Growth Factor Differentiation of Induced Pluripotent Stem Cell (iPSC)

May 1, 2026

Poultry Processing Equipment Market Analysis Report 2026: $6.37 Bn Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

May 1, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » Nasdaq Announces End-of-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date October 31, 2025
Press Release

Nasdaq Announces End-of-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date October 31, 2025

By News RoomNovember 11, 20252 Mins Read
Nasdaq Announces End-of-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date October 31, 2025
Share
Facebook Twitter LinkedIn Pinterest Email

NEW YORK, Nov. 11, 2025 (GLOBE NEWSWIRE) — At the end of the settlement date of October 31, 2025, short interest in 3,402 Nasdaq Global MarketSM securities totaled 14,079,841,205 shares compared with 13,834,913,159 shares in 3,382 Global Market issues reported for the prior settlement date of October 15, 2025. The October short interest represents 1.99 days compared with 2.09 days for the prior reporting period.

Short interest in 1,695 securities on The Nasdaq Capital MarketSM totaled 3,185,380,810 shares at the end of the settlement date of October 31, 2025, compared with 3,074,376,707 shares in 1,682 securities for the previous reporting period. This represents a 1.00 day average daily volume; the previous reporting period’s figure was 1.00.

In summary, short interest in all 5,097 Nasdaq® securities totaled 17,265,222,015 shares at the October 31, 2025 settlement date, compared with 5,064 issues and 16,909,289,866 shares at the end of the previous reporting period. This is 1.54 days average daily volume, compared with an average of 1.61 days for the prior reporting period.

The open short interest positions reported for each Nasdaq security reflect the total number of shares sold short by all broker/dealers regardless of their exchange affiliations. A short sale is generally understood to mean the sale of a security that the seller does not own or any sale that is consummated by the delivery of a security borrowed by or for the account of the seller.

For more information on Nasdaq Short interest positions, including publication dates, visit
http://www.nasdaq.com/quotes/short-interest.aspx
or http://www.nasdaqtrader.com/asp/short_interest.asp.

About Nasdaq:
Nasdaq (Nasdaq: NDAQ) is a leading global technology company serving corporate clients, investment managers, banks, brokers, and exchange operators as they navigate and interact with the global capital markets and the broader financial system. We aspire to deliver world-leading platforms that improve the liquidity, transparency, and integrity of the global economy. Our diverse offering of data, analytics, software, exchange capabilities, and client-centric services enables clients to optimize and execute their business vision with confidence. To learn more about the company, technology solutions, and career opportunities, visit us on LinkedIn, on X @Nasdaq, or at www.nasdaq.com.     

Media Contact:
Sam Raffalli
[email protected]

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/e585a278-c7c8-445a-8746-4b0dc3ab8c62

NDAQO

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

Hen (Chicken) Market Analysis Report 2026: $379.8 Bn Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

Zapdos Labs Raises $500K to Bring AI Video Agents to Factory Floors

Pharmaceutical Manufacturing Software Market Analysis Report 2026: $7.87 Bn Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

Pluristyx and Qkine Announce a Reciprocal Distribution Agreement in Support of Optimized Growth Factor Differentiation of Induced Pluripotent Stem Cell (iPSC)

Poultry Processing Equipment Market Analysis Report 2026: $6.37 Bn Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

Rituximab Biosimilars Market Trastuzumab Biosimilars Market Research Analysis Report 2026: $6.2 Bn Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

Trastuzumab Biosimilars Market Analysis Report 2026: $24.48 Bn Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

CereAura Aims to Simplify Autism Diagnosis and Therapy Through AI-Driven Insights

AITRADEBTC Introduces AiTradeBtc Automated Cryptocurrency Trading Platform

Editors Picks

Zapdos Labs Raises $500K to Bring AI Video Agents to Factory Floors

May 1, 2026

Pharmaceutical Manufacturing Software Market Analysis Report 2026: $7.87 Bn Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

May 1, 2026

Pluristyx and Qkine Announce a Reciprocal Distribution Agreement in Support of Optimized Growth Factor Differentiation of Induced Pluripotent Stem Cell (iPSC)

May 1, 2026

Poultry Processing Equipment Market Analysis Report 2026: $6.37 Bn Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

May 1, 2026

Latest News

Rituximab Biosimilars Market Trastuzumab Biosimilars Market Research Analysis Report 2026: $6.2 Bn Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

May 1, 2026

Trastuzumab Biosimilars Market Analysis Report 2026: $24.48 Bn Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

May 1, 2026

CereAura Aims to Simplify Autism Diagnosis and Therapy Through AI-Driven Insights

May 1, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version